MALDI mass spectrometry in prostate cancer biomarker discovery

被引:31
作者
Flatley, Brian [1 ,2 ]
Malone, Peter [2 ]
Cramer, Rainer [1 ]
机构
[1] Univ Reading, Dept Chem, Reading RG6 6AD, Berks, England
[2] Royal Berkshire Hosp, Urol Res Dept, Reading RG1 5AN, Berks, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2014年 / 1844卷 / 05期
关键词
Prostate cancer; Biomarkers; MALDI MS; MS profiling; MS imaging; ASSISTED-LASER-DESORPTION/IONIZATION; SELDI-TOF; ELECTROSPRAY-IONIZATION; DESORPTION IONIZATION; PROTEOMIC ANALYSIS; SCREENING-TEST; SERUM; IDENTIFICATION; PROTEINS; PEPTIDES;
D O I
10.1016/j.bbapap.2013.06.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix-assisted laser desorption/ionisation (MALDI) mass spectrometry (MS) is a highly versatile and sensitive analytical technique, which is known for its soft ionisation of biomolecules such as peptides and proteins. Generally, MALDI MS analysis requires little sample preparation, and in some cases like MS profiling it can be automated through the use of robotic liquid-handling systems. For more than a decade now, MALDI MS has been extensively utilised in the search for biomarkers that could aid clinicians in diagnosis, prognosis, and treatment decision making. This review examines the various MALDI-based MS techniques like MS imaging, MS profiling and proteomics in-depth analysis where MALDI MS follows fractionation and separation methods such as gel electrophoresis, and how these have contributed to prostate cancer biomarker research. This article is part of a Special Issue entitled: Biomarkers: A Proteomic Challenge. (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:940 / 949
页数:10
相关论文
共 86 条
[1]  
Adam BL, 2002, CANCER RES, V62, P3609
[2]  
Al-Ruwaili Jamal A., 2010, Cancer Genomics & Proteomics, V7, P93
[3]   Biomarkers and Heart Disease [J].
Albert, Michelle A. .
JOURNAL OF CLINICAL SLEEP MEDICINE, 2011, 7 (05) :S9-S11
[4]   Reproducibility in protein profiling by MALDI-TOF mass spectrometry [J].
Albrethsen, Jakob .
CLINICAL CHEMISTRY, 2007, 53 (05) :852-858
[5]   Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].
Atkinson, AJ ;
Colburn, WA ;
DeGruttola, VG ;
DeMets, DL ;
Downing, GJ ;
Hoth, DF ;
Oates, JA ;
Peck, CC ;
Schooley, RT ;
Spilker, BA ;
Woodcock, J ;
Zeger, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95
[6]   Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments [J].
Baggerly, KA ;
Morris, JS ;
Coombes, KR .
BIOINFORMATICS, 2004, 20 (05) :777-U710
[7]   Identification of Biological Tissues by Rapid Evaporative Ionization Mass Spectrometry [J].
Balog, Julia ;
Szaniszlo, Tamas ;
Schaefer, Karl-Christian ;
Denes, Julia ;
Lopata, Antal ;
Godorhazy, Lajos ;
Szalay, Daniel ;
Balogh, Lajos ;
Sasi-Szabo, Laszlo ;
Toth, Mikos ;
Takats, Zoltan .
ANALYTICAL CHEMISTRY, 2010, 82 (17) :7343-7350
[8]   Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies [J].
Barfield, Matt ;
Spooner, Neil ;
Lad, Rakesh ;
Parry, Simon ;
Fowles, Susan .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 870 (01) :32-37
[9]   Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer [J].
Bonnel, David ;
Longuespee, Remi ;
Franck, Julien ;
Roudbaraki, Morad ;
Gosset, Pierre ;
Day, Robert ;
Salzet, Michel ;
Fournier, Isabelle .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2011, 401 (01) :149-165
[10]   Selected Protein Monitoring in Histological Sections by Targeted MALDI-FTICR In-Source Decay Imaging [J].
Calligaris, David ;
Longuespee, Remi ;
Debois, Delphine ;
Asakawa, Daiki ;
Turtoi, Andrei ;
Castronovo, Vincent ;
Noel, Agnes ;
Bertrand, Virginie ;
De Pauw-Gillet, Marie-Claire ;
De Pauw, Edwin .
ANALYTICAL CHEMISTRY, 2013, 85 (04) :2117-2126